Joint collaboration enables clinical flow cytometry data analysis

Jan. 2, 2014
Quartz Bio SA, the SIB Swiss Institute of Bioinformatics, and Geneva Bioinformatics SA (GeneBio), have developed a platform for the analysis of flow cytometry data.

Quartz Bio SA, the SIB Swiss Institute of Bioinformatics (both in Lausanne, Switzerland), and Geneva Bioinformatics SA (GeneBio; Geneva, Switzerland), have developed a platform for the analysis of flow cytometry data. Dubbed MegaClust, the platform provides unprecedented, unbiased, in-depth data analysis in order to assess the safety and efficacy of drugs in clinical trials and identify biomarkers for patient stratification. Until now, such analysis was a hurdle for pharmaceutical companies and clinical research organizations, as clinical flow cytometry experiments generally contain a large number of samples collected from multiple sources, making curation and manual analysis time-consuming, not systematic, and therefore error-prone.

Related: Flow cytometry: Instruments, components, and impact

MegaClust enables automated, unbiased, and thorough identification of phenotypically similar cell populations in large datasets consisting of many samples. The technology allows reliable, quantitative cross-sample analyses and therefore provides a very powerful tool to stratify individuals and/or to analyze variations in cell subpopulations upon stimulations and candidate treatments.

Jérôme Wojcik, founder and CEO of Quartz Bio, says that “MegaClust achieved comparable quality as manual gating strategies and was in addition capable of identifying additional quality control problems undetected by classical approaches. We believe that the automated and systematic quality control of all files of a flow cytometry experiment enabled by MegaClust is the first instrumental step for a high-quality analysis. For those reasons, we are excited to keep collaborating with SIB and GeneBio in order to support our customer’s Precision Medicine projects with MegaClust."

The collaboration, which began in early 2013, brings together Quartz Bio’s expertise in clinical data analysis and the SIB's bioinformatics expertise. MegaClust is financially supported by the Commission for Technology and Innovation (KTI/CTI), the innovation promotion agency of the Swiss Confederation.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Sponsored Recommendations

Request a quote: Micro 3D Printed Part or microArch micro-precision 3D printers

April 11, 2024
See the results for yourself! We'll print a benchmark part so that you can assess our quality. Just send us your file and we'll get to work.

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Precision Motion Control for Sample Manipulation in Ultra-High Resolution Tomography

April 10, 2024
Learn the critical items that designers and engineers must consider when attempting to achieve reliable ultra-high resolution tomography results here!

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!